Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Chavin

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Annals of Surgery|October 1, 1991
Inhibition of macrophage-activating cytokines is beneficial in the acute septic responseH P Redmond, K D Chavin, J S Bromberg, et al.
The Journal of Experimental Medicine|January 1, 1994
Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survivalL Qin, K D Chavin, J Lin, et al.
Transplantation|March 15, 1994
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce toleranceK D Chavin, L Qin, J E Woodward, et al.
Transplantation Proceedings|February 1, 1993
Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine productionK D Chavin, L Qin, J Lin, et al.
Transplantation|April 1, 1993
Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effectsK D Chavin, L Qin, J Lin, et al.
Immunologic Research|January 1, 1994
Production of multiple murine CD2 receptor constructs using the baculovirus expression vector and a rapid dot-blot assayA J Kaplan, K D Chavin, L H Qin, et al.
Transplantation Proceedings|February 1, 1991
Effects of a polyclonal anti-TNF antibody on cell-mediated immunity in vivoK D Chavin, J S Bromberg, S L Kunkel, et al.
Transplantation|February 3, 1998
Anti-transferrin receptor monoclonal antibody: a novel immunosuppressantJ E Woodward, A L Bayer, K D Chavin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockadeK D Chavin, L Qin, R Yon, et al.
Transplantation|July 29, 1998
T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockadeJ E Woodward, A L Bayer, K D Chavin, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Annals of Surgery|October 1, 1991
Inhibition of macrophage-activating cytokines is beneficial in the acute septic responseH P Redmond, K D Chavin, J S Bromberg, et al.
The Journal of Experimental Medicine|January 1, 1994
Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survivalL Qin, K D Chavin, J Lin, et al.
Transplantation|March 15, 1994
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce toleranceK D Chavin, L Qin, J E Woodward, et al.
Transplantation Proceedings|February 1, 1993
Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine productionK D Chavin, L Qin, J Lin, et al.
Transplantation|April 1, 1993
Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effectsK D Chavin, L Qin, J Lin, et al.
Immunologic Research|January 1, 1994
Production of multiple murine CD2 receptor constructs using the baculovirus expression vector and a rapid dot-blot assayA J Kaplan, K D Chavin, L H Qin, et al.
Transplantation Proceedings|February 1, 1991
Effects of a polyclonal anti-TNF antibody on cell-mediated immunity in vivoK D Chavin, J S Bromberg, S L Kunkel, et al.
Transplantation|February 3, 1998
Anti-transferrin receptor monoclonal antibody: a novel immunosuppressantJ E Woodward, A L Bayer, K D Chavin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockadeK D Chavin, L Qin, R Yon, et al.
Transplantation|July 29, 1998
T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockadeJ E Woodward, A L Bayer, K D Chavin, et al.
Pageof 6